Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel
Published Feb 1, 2017 · M. Schaller, L. Almeida, A. Bewley
British Journal of Dermatology
130
Citations
4
Influential Citations
Abstract
Rosacea is currently treated according to subtypes. As this does not adequately address the spectrum of clinical presentation (phenotypes), it has implications for patient management. The ROSacea COnsensus panel was established to address this issue.
Study Snapshot
Key takeawayThe ROSacea COnsensus panel recommends treating rosacea based on phenotypes, rather than subtypes, to better address the diverse clinical presentations and improve patient management.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.